Streetbeat News

Earnings

THO

Thor Industries (NYSE:THO) is scheduled to release its quarterly earnings report on March 6, 2024. Analysts predict an EPS of $0.69. The company's past earnings performance shows mixed results with both misses and beats in previous quarters. Shares are currently trading at $127.12, reflecting a 43.6% increase over the last year. Investors are keenly awaiting the report, particularly for any positive guidance that could influence the stock's future direction.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 8:01 pm

REVG

REV Group (NYSE:REVG) is anticipated to report a quarterly EPS of $0.15 on March 6, 2024. Analysts and investors are keen on whether the company will surpass this estimate and provide positive future guidance. Historically, REV Group has exceeded EPS estimates, leading to positive stock price movements. The company's shares have seen a 64.8% increase over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 8:01 pm

AAPL

MTCH

At the Morgan Stanley Tech Conference, Match Group's CFO highlighted the impact of Apple's App Store fees on the company's margins, emphasizing that the 30% fee could be better invested in innovation rather than going to Apple.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 8:01 pm

VET

Vermilion Energy (NYSE:VET) is scheduled to release its quarterly earnings report on March 6, 2024, with analysts expecting an EPS of $0.52. The company's past earnings performance shows mixed results, with a notable miss last quarter leading to a slight share price drop. Over the last year, VET shares have declined by 13.14%, indicating potential concern among long-term shareholders as they await the upcoming earnings announcement.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 8:01 pm

DSGX

Descartes Systems Gr (NASDAQ:DSGX) is scheduled to release its quarterly earnings report on March 6, 2024, with an estimated EPS of $0.36. The company's past earnings performance shows mixed results, with a miss last quarter but a subsequent share price increase. Shares are currently trading at $90.52, up 11.56% over the last year. Investors are looking for not only an earnings beat but also positive guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 8:01 pm

CRWD

Crowdstrike's stock is trading lower due to a general downturn in the technology sector. The company is scheduled to announce its fourth-quarter earnings after the market closes today.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 7:46 pm

ALNY

RHHBY

Alnylam Pharmaceuticals Inc (ALNY) and Roche Holdings AG (RHHBY) announced positive results from the KARDIA-2 Phase 2 study of zilebesiran for hypertension, meeting its primary endpoint. Zilebesiran, an RNAi therapeutic, showed significant reductions in systolic blood pressure across three patient cohorts. The drug is co-developed with Roche and demonstrates a promising safety profile. A global Phase 2 study, KARDIA-3, is also underway. Despite the focus on the HELIOS-B trial for vutrisiran, analysts maintain an optimistic outlook on Alnylam, particularly for its TTR silencers, with an Outperform rating reaffirmed. ALNY shares dropped 1.22% to $148.21.

Portfolio Pulse from Vandana Singh

March 05, 2024 | 7:38 pm

FCUS

FFTY

GTLB

GitLab Inc (NASDAQ:GTLB) reported Q4 revenue of $163.78 million, a 33.3% increase YOY, beating estimates. EPS was $0.15, surpassing the $0.08 estimate. However, fiscal 2025 guidance disappointed, leading to a 20.60% drop in stock price to $59.15. Analysts from RBC Capital, DA Davidson, Canaccord Genuity, and Mizuho provided mixed reviews, adjusting price targets and expectations. Exposure to GitLab can also be gained through Tidal ETF Trust II Pinnacle Focused Opportunities ETF (NYSE:FCUS) and Innovator IBD 50 ETF (NYSE:FFTY).

Portfolio Pulse from Anusuya Lahiri

March 05, 2024 | 7:36 pm

C

Citi CEO announced at the RBC Capital Markets Conference that they expect the markets revenue to decline by 8%-12% in Q1 year on year, following a strong Q1 2023.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 7:35 pm

C

Citi's CEO announced at the RBC Capital Markets Conference that they expect the investment banking revenue to grow by a low-teens percentage in the first quarter.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 7:21 pm